Introduction
Childhood type 1 diabetes (T1D) is an organ-specific autoimmune disease with a multifactorial etiopathogenesis [1, 2] . During the last three decades, the incidence of T1D has increased in nearly all populations studied [3, 4] . Variance in the major histocompatibility complex region encoding the human leucocyte antigen (HLA) on chromosome 6p21 is the strongest genetic contributor in T1D [5] , but an increased proportion of low-risk HLA haplotypes and a decreased median age at clinical onset points towards a heightened environmental pressure [4, 6, 7] .
T cells have been well established in T1D etiopathogenesis [8, 9] , but B cells and autoantibodies may also play a pivotal accessory role in the autoimmune response, for example by inducing and/or enhancing the autoimmune T cell response [10] [11] [12] . B cells may especially be of importance for initiating or fuelling the autoimmune response in patients diagnosed with T1D before the age of 7 years [13] , and B cell-depleting therapies have shown a partial effect of disease progression, especially in the youngest [14, 15] .
Active vitamin D [1,25-dihydroxyvitamin D (1,25 (OH) 2 D)] is a secosteroid, which can alter gene expression in human cells that express the nuclear vitamin D receptor (VDR) [16] . VDR is expressed in both resting and activated B cells. Activated B cells also have the capacity to produce CYP27B1 (1a-hydroxylase), which converts 25- action are unknown [18, 19] -gene-environmental interactions may explain some of these differences [20] . Notably, in vitro studies have found that 1,25(OH) 2 D may inhibit human plasma cell generation and thereby regulate antibody production [12, 17] , but studies are lacking with regard to direct effects of 1,25(OH) 2 D on pre-existing plasma cells. Taken together, results primarily obtained from animal and human in vitro studies indicate that vitamin D might play a role in regulating differentiation and function of B cells, which may, in part, help prevent or halt autoimmune responses. Moreover, this effect may be more pronounced when addressing autoantibodies compared to total antibody production [12, 21] . However, only a few small human in vivo studies have examined the association between vitamin D exposure and T1D-associated autoantibody concentrations [22] [23] [24] .
We hypothesize that vitamin D plays a key role in regulating autoantibody production either by direct or indirect effects on the pathogenic plasma cell pool in the bone marrow, peripheral lymphoid tissue or tertiary lymphoid structures. We tested this hypothesis by relating 25(OH)D to autoantibodies against glutamic acid decarboxylase (isoform 65) (GADA) and insulinoma-associated antigen-2 (IA-2A) in 425 patients with childhood T1D and 433 siblings without T1D. As a secondary aim, we also related 25(OH)D concentrations to total concentrations of immunoglobulins (Ig), that is IgA, IgE, IgG and IgM in the same study sample. Further, we wanted to examine whether such associations were independent of/or modified by six well-known SNPs in genes involved in vitamin D transportation, hydroxylation from precursor metabolite to active metabolite, degradation of active metabolite, ligand-receptor affinity and function.
Materials and methods
Overview of study design. We performed a case-control study with participants originating from the Danish Registry of Childhood and Adolescent Diabetes (DanDiabKids). DanDiabKids was initiated in 1996 and includes all children with diabetes diagnosed before the age of 15 years [25] .
Study sample and identification of T1D. A random sample of 500 patients was selected from the DanDiabKids during 1997-2005. Blood samples were taken <3 months after diagnosis. The date of diagnosis was defined as the date of the first insulin injection. We frequency matched 500 siblings (controls) to the patient group with respect to age and year of blood sampling. Blood sampling was performed within 1 month from diagnosis in 90% of the samples in both patients and siblings from the same family. Due to insufficient biological material in the DanDiabKids biobank, 39 participants were excluded [26] . Notably, participants were selected alongside their sibling(s) by chance due to the random sampling strategy. This study sample consists of 203 sibling-pairs (see specific distribution in Svensson et al. [27] ). Serum samples from the DanDiabKids have been stored at À80°C (À112°F).
Using this study sample, we have published papers on the relationship between (i) 25(OH)D; (ii) SNPs in the vitamin D pathway; (iii) GADA and IA-2A; and (iv) Ig's and childhood T1D etiopathogenesis [26] [27] [28] [29] .
Outcome assessment. Assessment of GADA and IA-2A: GADA and IA-2A were measured in standard radio-ligand binding assays, described elsewhere [30] . In short, the antibody-bound antigen was separated from the freelabelled antigen using Protein A Sepharose and the unbound antigen was removed by extensive washing. The 97.5% cut-off limits for GADA and IA-2A positivity were 31 and 5 U/ml, respectively.
The GADA and IA-2A assays showed mean interassay coefficients of variation (CV) of 14% and intra-assays CV of 8%. Titration above 500 U/ml for GADA and 250 U/ml for IA-2A was not performed.
Assessment of antibody isotypes: Total quantification of four antibody isotypes was performed using rate nephelometry on IMMAGE (Beckman Coulter, Fullerton, CA) [31] . Lower limit of quantification (LLOQ) was 5 U/ml for IgE, 0.07 g/l for IgA, 0.3 g/l for IgG and 0.04 g/l for IgM. The performance limits of the assays were 5.5% for IgA, 6.5% for IgG and 8.7% for IgM.
Exposure assessment. Assessment of 25(OH)D in serum: Quantification of 25(OH)D was performed by highperformance liquid chromatography (HPLC), described elsewhere [32] . LLOQ for 25(OH)D was 10 nmol/l, with a CV of 8%.
Genotyping: The six SNPs were genotyped using TaqMan SNP genotyping assays and run on the TaqMan 7900 HT (Applied Biosystems, Foster City, CA, USA) or the CFX384 (Bio-Rad) systems. The SNPs genotyped were Bsm1 (C>T) (rs1544410); Fok1 (C>T) (rs2228570); and Apa1 (A>C) (rs7975232) in VDR; rs4646536 (T>C) in CYP27B1; rs6013897 (T>A) in CYP24A1; and rs2282679 (A>C) in GC. Notably, in CYP27B1, two SNPs rs4646536 (+2838 T>C) and rs10877012 (À1260 C>A) have previously been genotyped. Nonetheless, as they are in perfect linkage disequilibrium [33] , we only genotyped rs4646536 [29] .
Time-resolved fluorometry was used for the identification of HLA-DQB1 alleles, see details elsewhere [34] . Risk categorization of HLA-DQB1 genotypes is presented in Table 1 .
Other variables: A set of a priori selected variables were included in the adjusted models, that is case status (patient or sibling), sex (male or female), age at blood sampling Statistical analysis. Analyses were conducted in R version 3.2.0 (http://www.r-project.org) using the survival package [35] .
No prestudy power calculation was performed, because all biomarker and genetic variables were available for this study population prior to hypothesis generation.
The relative change (RC) in the mean concentration of GADA, IA-2A and antibody isotypes by a 10 nmol/l increase in total 25(OH)D (25(OH)D 2 + 25(OH)D 3 ) concentration was modelled by a robust log-normal regression model, which takes into account that measurements are potentially both left and right censored and allow for correlation within cluster [36, 37] . To specifically account for correlation, within-cluster inference was based on a working independence generalized estimation equation (GEE) approach. The cluster was equivalent to family/ sibling ID. Likelihood-ratio estimates of mean ratios and accompanying confidence limits are calculated on a log scale and transformed back to the original scale. Only participants with complete information on all variables were included in the adjusted analyses.
Overall functional misspecification by including 25-(OH)D as a continuous variable was assessed by a lack-of-fit test. Specifically, we included a quadratic term of 25(OH)D and tested if this alternative model fitted the data better using a likelihood-ratio test.
Sensitivity analyses: SNPs and interaction: We examined whether the relationship between antibody concentrations and 25(OH)D was independent of common SNPs in the vitamin D pathway -the six SNPs are all included at the sametimeineachmodel.Wealsoinvestigatedwhetherthe association between 25(OH)D and antibody concentrations was modified by SNP allele carrier status. Potential effect modification due to SNPs was examined one SNP at a time.
25(OH)D and seropositivity status: To investigate whether 25(OH)D was associated with seropositivity to both GADA and IA-2A, adjusted odds ratios (ORs) and accompanying confidence limits were estimated by logistic regression.
Age and interaction: Finally, we wanted to examine whether the age categories, constructed based on the findings by Leete and colleagues [0-6.99, 7-12.99 and <13 years of age], modified the effect of 25(OH)D on GADA and IA-2A in the patient group [13] . Further, an interaction term with age as a continuous variable was also tested.
P-values are evaluated at a 5% significance level. Due to the explanatory nature of this study, no penalty for multiple testing was applied.
Ethics. The study was performed in accordance with the Helsinki II Declaration and approved by the Danish Ethical Committee (H-KA-20070009). All of the patients, their parents or guardians gave informed consent.
Results
Four hundred and twenty-five patients and 433 siblings had information available for all variables, excluding SNPs, of the 961 participants with sufficient biological material in the DanDiabKids biobank. Of these, 401 patients and 392 siblings had information on all six SNPs. Distributions of these variables are presented in Tables 1 and 2 .
The median 25(OH)D concentration was 62.0 nmol/l in the patients and 58.0 nmol/l in the siblings. The median age was 10.4 years in the patients and 10.3 years in the siblings (Table 1) . Of the 858 participants, 88.3% of the patients and 6.2% of the siblings were positive for a minimum of one autoantibody. Additionally, 51.8% of the patients and 1.8% of the siblings were positive for both GADA and IA-2A.
Association between GADA and 25(OH)D
We found no association between GADA and 25(OH)D concentrations [adjusted RC per 10 nmol/l increase: 1.00; 95% confidence interval (CI): 0.98-1.02]. We also examined whether a nonlinear association existed between GADA and 25(OH), but found no sign of such an association (P = 0.26; Fig. 1 ). No sign of nonlinear associations was found (Fig. 3A-D) .
Sensitivity analyses

SNPs and interaction
Additional adjustment for the six SNPs did not change the null findings, between antibodies and 25(OH)D, in any of the above-mentioned adjusted models. We found no evidence for the modification of allele carrier status, for the six SNPs, on the relationship between 25(OH)D and all of the examined antibodies in the adjusted models.
Bsm1, Apa1, CYP27B1 and CYP24A1 were not independently associated with the antibody concentrations, but carriers homozygous for the major GC allele had lower 
25(OH)D and seropositivity status
We found no evidence that 25(OH)D predicted the likelihood of having both autoantibodies detected versus either being single autoantibody positive (P = 1.00) or autoantibody negative (P = 0.77).
Age and interaction
Prespecified age categories, as a surrogate for the insulitic profile, did not modify the effect of 25(OH)D on GADA or IA-2A concentrations. Noteworthy, when using age as a continuous variable, we found no sign of interaction either.
Discussion
The generation of plasma cells from precursor B cells, upon activation of the latter, is a complex process, and many questions still remain unanswered [38] . Long-term surviving plasma cells that produce antibodies can be retained in the bone marrow or in the secondary lymphoid tissue, for example lymph nodes, but such a state requires extrinsic factors/survival factors, provided by the microenvironment, for example by bone marrow stromal cells and eosinophils, to be upheld [39] , and the function of such cell types has been shown, in vitro, to be modulated by vitamin D [40] [41] [42] . Despite the fact that such discoveries are biologically compelling, we did not find evidence for direct or indirect in vivo regulatory effects of 25(OH)D concentrations on autoantigen-specific plasma cells' production of GADA or IA-2A in a paediatric population comprising of newly diagnosed patients with T1D and their healthy siblings. In addition, we found no sign that higher 25(OH)D concentrations hampered total antibody production in the same study sample. One of the main reasons for our null findings regarding the relationship between 25(OH)D and concentrations of GADA and IA-2A could be due to timing [43] . Autoantibodies directed against the antigens of the pancreatic b cells are present years before clinical onset of T1D; that is, the autoantigen-specific plasma cells have already been generated [44] . In vitro studies imply that inhibitory effects of 1,25(OH) 2 D may only indirectly affect the plasma cell pool by inhibiting their formation and that already developed plasma cells are resistant to direct effects of 1,25(OH) 2 D [17, 45] . Notably, it is also important to state that few of the in vitro findings that have suggested a beneficial immunological role of vitamin D in B cell biology have not been replicated in human in vivo studies, which has been called the 'tube-versus-body paradox' [46] . In laboratory studies, cell cultures are often exposed to supra-physiological doses of 1,25(OH) 2 D and isolated from complex in vivo microenvironments, for example germinal centres and the bone marrow concerning plasma cells generation and function.
Autoantibodies
Three studies focusing on the association between T1D-associated autoantibodies and 25(OH)D have shown opposing results, but unfortunately, they have all been small or poorly designed. Therefore, describing them in detail does not seem sensible [22] [23] [24] . The association between vitamin D and T1D-associated autoantibodies could also be dependent on ultraviolet radiation (UVR) exposure. An Australian study (including 247 newly diagnosed cases) found an inverse association between GADA concentrations and composite sun exposure index in patients below 5 years of age, but not in patients aged 5 years or older. This finding indicates an age-differentiated role of UVR on pathogenic plasma cell formation and/or function, which could be supported by the recent discovery of a more substantial role of B cells in children diagnosed with T1D before the age of 7 years [13, 47] -a subphenotype histologically characterized with a more aggressive inflammatory infiltrate and a lower proportion of residual insulin-containing islets. We found no evidence of an age-differentiated effect on the association between 25 (OH)D and GADA or IA-2A, which could indicate that the association between higher UVR exposure and reduced GADA concentrations in the youngest may be vitamin D independent, but this is still unclear and requires replication [48] . [50] . Another clinical trial (n = 175) coadministered 1.0 lg of 1,25(OH) 2 D 3 (calcitriol) with an influenza vaccination, but found no effect of calcitriol on specific antigen titres at 1 and 3 months post-vaccination [51] . Lastly, a large British study (n = 7288) demonstrated a nonlinear association where 25(OH)D concentrations below 25 nmol/l and above 135 nmol/l increased IgE concentrations. Noteworthy, this study also found that a SNP (rs10877012 (À1260 C>A)) in CYP27B1 gene was associated with total IgE concentrations [52] . Contrary to the latter study, we found neither linear nor nonlinear associations between concentrations of 25(OH)D and total IgE. Additionally, we found no association between a SNP in the CYP27B1 gene that is in perfect linkage disequilibrium with the SNP genotyped in the study by Hypp€ onen et al., and total IgE or other antibody isotype concentrations. These conflicting results may be due to different age populations. Intriguingly, a recent large-scale study using a Mendelian randomization approach found no evidence for a genetically determined decrease in 25(OH)D concentrations results in elevated total IgE [53] . In sum, these lines of evidence indicate that vitamin D is primarily important in establishing immunological homeostatis and may even have beneficial effects on humoral immunity, but concentrations above 135 nmol/l could potentially increase the risk of developing atopic diseases.
Strengths and weaknesses
Our study has several strengths: (i) we have a large population-based sample size; (ii) to our knowledge, we are the first study to have included SNPs in the vitamin D metabolism pathway when examining the association between 25(OH)D and autoantibodies and total antibody isotypes in a paediatric population; and (iii) we use a robust log-normal regression model that accounts for both right and left censoring of antibody concentrations, which also accounts for clustering within the family in the model. Some limitations also require attention: (i) using antibody concentrations as a proxy for the humoral immune response is a simplistic approach, which is not able to capture possible actions of vitamin D on antibody-independent functions of B cells such as inhibiting T cell co-stimulation and enhanced activity of IL-10-producing B cells (regulatory subset) [46, 54] ; (ii) we only have single measurements; (iii) zinc transporter autoantibodies (ZnT8A) and insulin autoantibodies (IAA) were not assessed, but we measured two of the most common autoantibodies in T1D [55] ; (iv) we did not evaluate whether 1,25(OH)2D could influence antibody concentrations, but this metabolite only has a half-life of a few hours making it a less reliable exposure variable [56] ; (v) due to only approximately a quarter of our study population is below 7 years of age, this reduces our power to detect an association between 25(OH) D and autoantibodies in this age group where B cells may play a more pronounced role in the T1D pathogenesis, but we found no sign of an interaction between 25(OH)D and age; and (vi) our study only examined associations between 25(OH)D and antibody concentrations, and not a causal effect of vitamin D.
Conclusion
Our relatively large-scale population-based case-control study shows that normal variation in 25(OH)D is unlikely to have a clinically important effect on antibody concentrations in a paediatric population of newly diagnosed patients with T1D and their healthy siblings. However, we cannot exclude that higher concentrations of 25(OH)D than found in our data can modify antibody concentrations.
